Search

The development of the proton exchange membrane water electrolyzer (PEMWE) is still limited by the prohibitive cost and scarcity of iridium (Ir)‐based oxygen evolution reaction (OER) catalyst. This work presents a novel catalyst synthesized by precursor‐atomization and rapid joule‐heating method, successfully doping iridium atoms into polyvalent tungsten blends (W0, W5+, W6+) based on titanium substrate. The vacancy engineering of unsaturated tungsten oxide (W5+, W6+) reconstructs the electronic structure of the catalyst surface, which resulting in the low‐valence state iridium species, avoiding excessive oxidation of iridium and accelerating the catalytic kinetics. Meanwhile, metallic tungsten (W0) improves the conductivity of catalyst and guarantees the stable existence of oxygen vacancy. The TiIrWOx possesses excellent performance in acidic OER catalysis, requiring overpotential of only 181 mV to drive 10.0 mA cm−2, and exhibiting a high mass activity of 753 A gIr−1 at an overpotential of 300 mV. The membrane electrode assembly (MEA) with TiIrWOx as anode electrocatalyst can reduce the Ir consumption amount by >60% compared to commercial IrO2, and it can operated over 120 h at a current density of 1.0 A cm−2. [ABSTRACT FROM AUTHOR]

Key message: A novel light-dependent dominant lesion mimic mutant with enhanced multiple disease resistance was physiologically, biochemically, and genetically characterized; the causal gene was fine mapped to a 909 kb interval containing 38 genes. Identification of genes that confer multiple disease resistance (MDR) is crucial for the improvement of maize disease resistance. However, very limited genes are identified as MDR genes in maize. In this study, we characterized a dominant disease lesion mimics 8 (Les8) mutant that had chlorotic lesions on the leaves and showed enhanced resistance to both curvularia leaf spot and southern leaf blight. Major agronomic traits were not obviously altered, while decreased chlorophyll content was observed in the mutant, and the genetic effect of the Les8 mutation was stable in different genetic backgrounds. By BSR-seq analysis and map-based cloning, the LES8 gene was mapped into a 909 kb region containing 38 candidate genes on chromosome 9 wherein no lesion mimic or disease-resistance genes were previously reported. Using transcriptomics analysis, we found that genes involved in defense responses and secondary metabolite biosynthesis were enriched in the significantly up-regulated genes, while genes involved in photosynthesis and carbohydrate-related pathways were enriched in the significantly down-regulated genes in Les8. In addition, there was an overaccumulation of jasmonic acid and lignin but not salicylic acid in Les8. Taken together, this study revealed candidate genes and potential mechanism underlying Les8-conferred MDR in maize. [ABSTRACT FROM AUTHOR]

Proton exchange membrane water electrolysis (PEMWE) can be coupled with renewable energy power generation technology and is considered to be a highly promising hydrogen production technology. However, the acidic electrolyte environment, as well as the numerous sulfonic acid groups on the proton exchange membrane surface, can seriously corrode the oxygen evolution reaction (OER) catalyst and even cause deactivation. To develop an efficient acidic OER catalyst, the IrOx/WO3 heterostructure OER catalyst was prepared by a hydrothermal-calcination method. The coordination environment of IrOx was regulated through the electronic rearrangement effect, improving the OER activity and stability of the catalyst in acidic media. The prepared IrOx/WO3 exhibits excellent OER activity in 0.5 M H2SO4, with an overpotential of only 260 mV to achieve a current density of 10 mA cm−2 and a mass activity of 176.8 A gIr−1. It can stably operate for over 12 hours at a current density of j = 10 mA cm−2. [ABSTRACT FROM AUTHOR]

MYC has been identified to profoundly influence a wide range of pathologic processes in cancers. However, the prognostic value of MYC-related genes in pancreatic adenocarcinoma (PAAD) remains unclarified. Gene expression data and clinical information of PAAD patients were obtained from The Cancer Genome Atlas (TCGA) database (training set). Validation sets included GSE57495, GSE62452, and ICGC-PACA databases. LASSO regression analysis was used to develop a risk signature for survival prediction. Single-cell sequencing data from GSE154778 and CRA001160 datasets were analyzed. Functional studies were conducted using siRNA targeting RHOF and ITGB6 in PANC-1 cells. High MYC expression was found to be significantly associated with a poor prognosis in patients with PAAD. Additionally, we identified seven genes (ADGRG6, LINC00941, RHOF, SERPINB5, INSYN2B, ITGB6, and DEPDC1) that exhibited a strong correlation with both MYC expression and patient survival. They were then utilized to establish a risk model (MYCsig), which showed robust predictive ability. Furthermore, MYCsig demonstrated a positive correlation with the expression of HLA genes and immune checkpoints, as well as the chemotherapy response of PAAD. RHOF and ITGB6, expressed mainly in malignant cells, were identified as key oncogenes regulating chemosensitivity through EMT. Downregulation of RHOF and ITGB6 reduced cell proliferation and invasion in PANC-1 cells. The developed MYCsig demonstrates its potential in enhancing the management of patients with PAAD by facilitating risk assessment and predicting response to adjuvant chemotherapy. Additionally, our study identifies RHOF and ITGB6 as novel oncogenes linked to EMT and chemoresistance in PAAD. [ABSTRACT FROM AUTHOR]